IM Inj in deltoid muscle. Primary vaccination schedule of 2 doses (0.5 mL each). Initial dose followed by 2nd dose 2-6 mth later. Immunodeficient or immunosuppressed individual 2nd dose can be given 1-2 mth after initial dose.
Not indicated for prevention of primary varicella infection. Not to be administered as intravascular, intradermal or SC. Postpone vaccination in subjects suffering from acute severe febrile illness. Syncope (fainting). Patients w/ thrombocytopenia or any coagulation disorder. Consider review of medical history & clinical exam prior to immunisation. Pregnancy & lactation. Increased risk of Guillain-Barré syndrome in elderly ≥65 yr.
More frequent adverse reactions eg, fever & shivering in concomitant use w/ unadjuvanted seasonal flu vaccine, 23-valent pneumococcal polysaccharide vaccine (PPV23). Administer at different inj site if to be given at the same time as another injectable vaccine.
Sign Out
